학술논문
Combination of Ibrutinib Plus Venetoclax with MRD-Driven Duration of Treatment Results in a Higher Rate of MRD Negativity in IGHV Unmutated Than Mutated CLL: Updated Interim Analysis of FLAIR Study
Document Type
Abstract
Author
Munir, Talha ; Pitchford, Alexandra ; Bloor, Adrian ; Pettitt, Andrew ; Patten, Piers E.M.; Forconi, Francesco ; Schuh, Anna; Fox, Christopher P; Gatto, Simona ; Kennedy, Ben ; Gribben, John ; Pemberton, Nicholas ; Sheehy, Oonagh ; Preston, Gavin ; Howard, Dena ; Hockaday, Anna ; Cairns, David ; Jackson, Sharon ; Greatorex, Natasha ; McWhirter, Nichola ; Shingles, Jane ; Cwynarski, Kate ; Paneesha, Shankara; Allsup, David ; Rawstron, Andrew ; Hillmen, Peter
Source
In Blood 15 November 2022 140 Supplement 1:231-233
Subject
Language
ISSN
0006-4971